Wenxuan Bu

发表

PKC inhibition of sotrastaurin has antitumor activity in diffuse large B-cell lymphoma via regulating the expression of MCT-1

Gaomei Chang, W. Xiao, Dandan Yu, 2018, Acta biochimica et biophysica Sinica.

Dual inhibition of mTORC1/2 by DCZ0358 induces cytotoxicity in multiple myeloma and overcomes the protective effect of the bone marrow microenvironment.

Weiliang Zhu, Zhijian Xu, Dandan Yu, 2018, Cancer letters.

Targeting the PI3K/Akt/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progression

Weiliang Zhu, Gege Chen, Gaomei Chang, 2018, Acta biochimica et biophysica Sinica.

Novel cyclophosphamide of natural products osalmide and pterostilbene induces cytotoxicity and cell cycle arrest in diffuse large B-cell lymphoma cells.

Weiliang Zhu, Gege Chen, Zhijian Xu, 2020, Acta biochimica et biophysica Sinica.

N6‐methyladenosine reader YTHDF3 regulates melanoma metastasis via its ‘executor'LOXL3

Yingjie Kong, Yan Wang, J. Xiong, 2022, Clinical and translational medicine.

Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway.

Weiliang Zhu, Gege Chen, W. Xiao, 2019, Cancer letters.

A novel silicone derivative of natural osalmid (DCZ0858) exerts anti-multiple myeloma activity by promoting cell apoptosis and inhibiting cell cycle and mTOR signaling

Weiliang Zhu, Wang, Zhijian Xu, 2021 .

Identification of Metabolism-Related Genes Influencing Prognosis of Multiple Myeloma Patients

Yang Yang, Wenxuan Bu, Rui Wang, 2021, Journal of healthcare engineering.

Dihydrocelastrol exerts potent antitumor activity in mantle cell lymphoma cells via dual inhibition of mTORC1 and mTORC2.

Weiliang Zhu, Zhijian Xu, Yong Zhang, 2018, International journal of oncology.

A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe

Weiliang Zhu, Gege Chen, Zhijian Xu, 2020, Journal of experimental & clinical cancer research : CR.

A novel silicone derivative of natural osalmid (DCZ0858) exerts anti-multiple myeloma activity by promoting cell apoptosis and inhibiting cell cycle and mTOR signaling.

Weiliang Zhu, Zhijian Xu, Jumei Shi, 2021, American journal of translational research.